Digital marketing firm One to One Interactive has named Gayatri Bhalla group director of its life sciences division.
In her new role, Bhalla will be responsible for the strategic direction of the life science practice, which oversees interactive accounts for GlaxoSmithKline’s Avandia, Advair, Wellbutrin, Lamictal (bipolar and epilepsy) and Valtrex, as well as Roche’s transplantation franchise, including Cellcept and Zenapax.
“A shift is taking place in the consumer health space, as more and more people are actively engaging in the use of interactive mediums to validate trusted vendors and to make well-informed purchasing decisions,” Bhalla said. “I am pleased to offer my knowledge and insight.”
Bhalla has been in the life sciences area since 1997, working with GlaxoSmithKline, Pfizer and Millennium Pharmaceuticals.
From the June 01, 2006 Issue of MM+M - Medical Marketing and Media
